Here are four things to know.
1. Salix develops products for hepatic encephalopathy, IBS with diarrhea, opioid-induced constipation and ulcerative colitis.
2. Salix comprised approximately 18 percent of Valeant’s $8.7 billion revenue for fiscal year 2017.
3. Valeant acquired Salix in 2015.
4. Salix is Valeant’s most successful business after its Bausch + Lomb segment.
More articles on gastroenterology:
GI leader to know: Dr. Terry Baldwin of Illinois Gastroenterology Institute
Drs. Michael Kaczanowski, Seth Gross & more: 3 GI physicians making headlines
Self-employed gastroenterologists earn $24k more than employed: 4 statistics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.